Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.
Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P, Agrup M, Dahl L, Gubanski M, Gojon H, Brahme CJ, Rydén I, Jakola AS, Vik-Mo EO, Lie HC, Asphaug L, Hervani M, Kristensen I, Rueegg CS, Olsen IC, Ledal RJ, Degsell E, Werlenius K, Blomstrand M, Brandal P. Heggebø LC, et al. Among authors: vik mo eo. BMJ Open. 2023 Mar 20;13(3):e070071. doi: 10.1136/bmjopen-2022-070071. BMJ Open. 2023. PMID: 36940951 Free PMC article.
Variations in the management of diffuse low-grade gliomas-A Scandinavian multicenter study.
Munkvold BKR, Solheim O, Bartek J Jr, Corell A, de Dios E, Gulati S, Helseth E, Holmgren K, Jensdottir M, Lundborg M, Mireles EEM, Mahesparan R, Tveiten ØV, Milos P, Redebrandt HN, Pedersen LK, Ramm-Pettersen J, Sjöberg RL, Sjögren B, Sjåvik K, Smits A, Tomasevic G, Vecchio TG, Vik-Mo EO, Zetterling M, Salvesen Ø, Jakola AS. Munkvold BKR, et al. Neurooncol Pract. 2021 Sep 4;8(6):706-717. doi: 10.1093/nop/npab054. eCollection 2021 Dec. Neurooncol Pract. 2021. PMID: 34777840 Free PMC article.
[Glioblastoma in adults].
Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T. Schipmann-Miletic S, et al. Tidsskr Nor Laegeforen. 2023 Jan 30;143(2). doi: 10.4045/tidsskr.22.0314. Print 2023 Jan 31. Tidsskr Nor Laegeforen. 2023. PMID: 36718891 Free article. Norwegian.
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study.
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P. Blakstad H, et al. Among authors: vik mo eo. Neurooncol Pract. 2023 Oct 3;11(1):36-45. doi: 10.1093/nop/npad063. eCollection 2024 Feb. Neurooncol Pract. 2023. PMID: 38222046 Free PMC article.
Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study.
Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T. Skaga E, et al. Among authors: vik mo eo. Acta Oncol. 2024 Mar 19;63:83-94. doi: 10.2340/1651-226X.2024.24970. Acta Oncol. 2024. PMID: 38501768 Free article.
55 results